These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Vuillemenot BR; Pulling LC; Palmisano WA; Hutt JA; Belinsky SA Carcinogenesis; 2004 Apr; 25(4):623-9. PubMed ID: 14656941 [TBL] [Abstract][Full Text] [Related]
4. A review of the histopathology of cigarette smoke-induced lung cancer in rats and mice. Hahn FF; Gigliotti AP; Hutt JA; March TH; Mauderly JL Int J Toxicol; 2007; 26(4):307-13. PubMed ID: 17661221 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804 [TBL] [Abstract][Full Text] [Related]
7. Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. Stinn W; Arts JH; Buettner A; Duistermaat E; Janssens K; Kuper CF; Haussmann HJ Toxicology; 2010 Sep; 275(1-3):10-20. PubMed ID: 20594951 [TBL] [Abstract][Full Text] [Related]
8. Chronic inhalation studies in mice. II. Effects of long-term exposure to 2R1 cigarette smoke on (C57BL/Cum x C3H/AnfCum)F1 mice. Henry CJ; Kouri RE J Natl Cancer Inst; 1986 Jul; 77(1):203-12. PubMed ID: 3459913 [TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025 [TBL] [Abstract][Full Text] [Related]
10. Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse. Stinn W; Berges A; Meurrens K; Buettner A; Gebel S; Lichtner RB; Janssens K; Veljkovic E; Xiang Y; Roemer E; Haussmann HJ Toxicology; 2013 Mar; 305():49-64. PubMed ID: 23357402 [TBL] [Abstract][Full Text] [Related]
11. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728 [TBL] [Abstract][Full Text] [Related]
12. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548 [TBL] [Abstract][Full Text] [Related]
13. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf. Wang Y; Zhang Z; Lubet R; You M Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer]. Zhang CY; Jin YT; Xu HY; Zhang H; Zhang WM; Sun XY; Tan C; Chen CM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):23-8. PubMed ID: 21287504 [TBL] [Abstract][Full Text] [Related]
16. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Belinsky SA; Klinge DM; Liechty KC; March TH; Kang T; Gilliland FD; Sotnic N; Adamova G; Rusinova G; Telnov V Carcinogenesis; 2004 Jun; 25(6):1063-7. PubMed ID: 14742312 [TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
18. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related]
19. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Cui X; Wakai T; Shirai Y; Hatakeyama K; Hirano S Toxicol Sci; 2006 Jun; 91(2):372-81. PubMed ID: 16543296 [TBL] [Abstract][Full Text] [Related]
20. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years. Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]